ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för CH-223191. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

15 träffar

Bibliografisk träff 2023-08-04

Aryl hydrocarbon receptors improve migraine-like pain behaviors in rats through the regulation of regulatory T cell/T-helper 17 cell-related homeostasis.

Yang L, Zhou Y, Zhang L, Wang Y, Zhang Y, Xiao Z.

Headache · comment; journal article · DOI 10.1111/head.14599

Bibliografisk träff 2023-06-23

Release from persistent T cell receptor engagement and blockade of aryl hydrocarbon receptor activity enhance IL-6-dependent mouse follicular helper T-like cell differentiation in vitro.

Sakamoto R, Takada A, Yamakado S, Tsuge H, Ito E, Iwata M.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0287746

Bibliografisk träff 2023-06-10

Ethyl Caffeate Can Inhibit Aryl Hydrocarbon Receptor (AhR) Signaling and AhR-Mediated Potentiation of Mast Cell Activation.

Nguyen PT, Nakamura Y, Tran NQV, Ishimaru K, Nguyen TA, Kobayashi Y, Watanabe-Saito F, Okuda T, Nakano N, Nakao A.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms24129997

Bibliografisk träff 2023-01-01

Control of Arterial Hypertension by the AhR Blocker CH-223191: A Chronopharmacological Study in Chronic Intermittent Hypoxia Conditions.

Pimpão AB, Sousa C, Correia MJ, Coelho NR, Monteiro EC, Melo Junior AF, Pereira SA.

Adv Exp Med Biol · journal article · DOI 10.1007/978-3-031-32371-3_4

Bibliografisk träff 2022-07-05

Blocking the Aryl Hydrocarbon Receptor Alleviates Myocardial Ischemia/Reperfusion Injury in Rats.

Wang JX, Wang BB, Yuan SZ, Xue K, Zhang JS, Xu AJ.

Curr Med Sci · journal article · DOI 10.1007/s11596-022-2601-9

Bibliografisk träff 2022-06-10

Expansion of Human Megakaryocyte-Lineage Progeny via Aryl Hydrocarbon Receptor Antagonism with CH223191.

Kim D, Shin DY, Liu J, Jeong NR, Koh Y, Hong J, Huang X, Broxmeyer HE, Yoon SS.

Stem Cell Rev Rep · research support, non-u.s. gov't; journal article · DOI 10.1007/s12015-022-10386-0

Bibliografisk träff 2022-06-02

Analgesic Activity of Cinnabarinic Acid in Models of Inflammatory and Neuropathic Pain.

Notartomaso S, Boccella S, Antenucci N, Ricciardi F, Fazio F, Liberatore F, Scarselli P, Scioli M, Mascio G, Bruno V, Battaglia G, Nicoletti F, Maione S, Luongo L.

Front Mol Neurosci · research-article; journal article · DOI 10.3389/fnmol.2022.892870

Bibliografisk träff 2022-03-18

Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia <i>via</i> Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation.

Atene CG, Fiorcari S, Mesini N, Alboni S, Martinelli S, Maccaferri M, Leonardi G, Potenza L, Luppi M, Maffei R, Marasca R.

Front Immunol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3389/fimmu.2022.832263

Bibliografisk träff 2020-05-19

First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia.

Coelho NR, Tomkiewicz C, Correia MJ, Gonçalves-Dias C, Barouki R, Pereira SA, Coumoul X, Monteiro EC.

Pharmacol Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.phrs.2020.104869

Bibliografisk träff 2019-07-18

Identification of new aryl hydrocarbon receptor (AhR) antagonists using a zebrafish model.

Jeong J, Kim KH, Kim DY, Chandrasekaran G, Kim M, Pagire SH, Dighe M, Choi EY, Bak SM, Kim EY, Shin MG, Choi SY, Ahn JH.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2019.07.030

Bibliografisk träff 2019-03-04

Impact of CH223191-Induced Mitochondrial Dysfunction on Its Aryl Hydrocarbon Receptor Agonistic and Antagonistic Activities.

Mohammadi-Bardbori A, Omidi M, Arabnezhad MR.

Chem Res Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.chemrestox.8b00371

Bibliografisk träff 2019-01-01

The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).

Leja-Szpak A, Góralska M, Link-Lenczowski P, Czech U, Nawrot-Porąbka K, Bonior J, Jaworek J.

Anticancer Agents Med Chem · research support, non-u.s. gov't; journal article · DOI 10.2174/1871520619666190415165212

Bibliografisk träff 2011-10-03

Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor.

Choi EY, Lee H, Dingle RW, Kim KB, Swanson HI.

Mol Pharmacol · comparative study; research-article; journal article; research support, n.i.h., extramural · DOI 10.1124/mol.111.073643

Bibliografisk träff 2010-07-15

CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor.

Zhao B, Degroot DE, Hayashi A, He G, Denison MS.

Toxicol Sci · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1093/toxsci/kfq217

Bibliografisk träff 2006-03-15

Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor.

Kim SH, Henry EC, Kim DK, Kim YH, Shin KJ, Han MS, Lee TG, Kang JK, Gasiewicz TA, Ryu SH, Suh PG.

Mol Pharmacol · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1124/mol.105.021832